ArticleComputational and structural biotechnology journal2025
ImmiR: A database of microRNAs associated with immune checkpoints and infiltrates.
Article in Computational and structural biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Emerging evidence indicates that microRNAs (miRNAs) play crucial roles in regulating immune checkpoint (IC) genes, thereby modulating IC-related pathways and the behavior of tumor-infiltrating lymphocytes (TILs), thus showing significant potential as a treatment modality in combination therapies with IC inhibitors. Although previous studies primarily focused on single cancer types or individual miRNAs, there is a lack of comprehensive research exploring the complex interactions between miRNAs, IC pathways, and TILs in multiple cancer types. Methods: To address this gap, we developed a database called ImmiR that systematically integrates curated data from scientific literature and bioinformatics analyses and defines IC pathways and their ligands/receptors. Using integrated bioinformatics approaches, ImmiR investigated the interactions between miRNAs and IC genes, as well as the associations between miRNAs and TILs. Results: ImmiR identified miRNAs targeting genes across 32 immune checkpoint pathways and found associations with 84 immune cell types. As a user-friendly web-based platform, ImmiR provides functional visualizations that facilitate the identification of significant associations from various perspectives such as miRNAs, IC genes/pathways, and cancer types. The database is freely accessible at https://immir.bioinfomics.org/. Conclusions: By filling gaps in data resources, ImmiR serves as a vital tool for discovering novel therapeutic targets, refining miRNA-based immunotherapies, and advancing precision medicine in cancer immunotherapy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.